iShares Large Cap 10% Target Buffer Sep ETF (STEN)
Live price chart, market sentiment, and community perspectives for iShares Large Cap 10% Target Buffer Sep ETF (CBOE: STEN).
Live price chart, market sentiment, and community perspectives for iShares Large Cap 10% Target Buffer Sep ETF (CBOE: STEN).
On our desk, we are closely monitoring STEN's structural mechanics. The ETF utilizes a defined outcome strategy on the iShares Core SandP 500 ETF (IVV), aiming to shield investors against the first 10% of losses over a 12-month period. Because the upside cap and downside buffer reset every year at the end of September, clients must maintain their position for the full cycle to realize the intended risk profile.
From a market sentiment perspective, institutional sponsorship remains relatively focused, with about 8 hedge funds and large institutions holding roughly $18.4 million in Q2 2026. While positioning shifts are modest, the fund's net expense ratio of 0.50% and a trailing 30-day SEC yield around 0.66% offer a predictable cost structure for tactical asset allocators looking for buffered large-cap U.S. equity exposure.
As a risk manager reviewing STEN's performance metrics as of mid-2026, I note its YTD NAV total return sits at 11.52% as of August, trailing the underlying benchmark's 10.21% to 15.20% performance window depending on the exact trailing intervals. The net asset value hovers around $28.26 to $28.44, exhibiting low single-day volatility consistent with its buffered strategy mandate.
When evaluating STEN for risk-managed equity portfolios, our quant team highlights that the fund achieves its downside protection by holding IVV shares alongside a combination of FLEX or exchange-traded put and call options. The options overlay generates the income required to fund the 10% buffer, which inherently caps the upside price return participation relative to the benchmark.
In our technical analysis protocols, we look at Danelfin's AI-powered signals and 3-month horizon parameters for STEN, which suggest specific entry points near $28.40. However, traders must keep in mind that holding duration is critical; exiting prior to the annual September reset can expose the portfolio to unhedged drawdowns that bypass the targeted buffer protection.
Explore plasma cleansing, somatic organ swaps, and BCI.